Literature DB >> 7680698

Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. Priming in vitro and in vivo for class I-restricted recognition of soluble antigen.

W Chen1, F R Carbone, J McCluskey.   

Abstract

Class I major histocompatibility complex (MHC)-restricted cytotoxic T lymphocyte responses to ovalbumin (OVA) were evaluated following delivery of soluble antigen mixed with commercial liposomes or by electroporation of soluble protein into target cells. Splenic antigen presenting cells (APC) and transfected L cell lines were sensitised for recognition by OVA-specific, class I-restricted T hybridomas when antigen was introduced by either method into live cells. Delivery of soluble OVA by both electroporation and commercial liposomes proved more efficient than osmotic loading in sensitising for class I presentation. OVA-specific cytotoxic T lymphocytes (CTL) were effectively primed in naive mice following reinjection of spleen cells pulsed with soluble OVA encapsulated by liposomes or electroporated in vitro. These CTL recognised the well defined OVA257-264 determinant in association with H-2Kb and were derived under conditions where CTL activity obtained from cross priming by soluble OVA alone was undetectable. In addition, using electroporation and commercial liposomes, the loading of APC for OVA recognition required intact MHC-linked antigen presentation genes deleted in the T2-Kb cell line. Antigen delivery to APC by electroporation and commercial liposomes provides a simple and efficient way of studying class I-restricted T cell recognition of soluble protein antigens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680698     DOI: 10.1016/0022-1759(93)90007-t

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  Clustering class I MHC modulates sensitivity of T cell recognition.

Authors:  David R Fooksman; Gigi Kwik Grönvall; Qing Tang; Michael Edidin
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

2.  Tat-mediated protein delivery can facilitate MHC class I presentation of antigens.

Authors:  P Moy; Y Daikh; B Pepinsky; D Thomas; S Fawell; J Barsoum
Journal:  Mol Biotechnol       Date:  1996-10       Impact factor: 2.695

Review 3.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

4.  The CD4+ T-cell response to protein immunization is independent of accompanying IFN-gamma-producing CD8+ T cells.

Authors:  A G Doyle; L Ramm; A Kelso
Journal:  Immunology       Date:  1998-03       Impact factor: 7.397

5.  Antigen processing and presentation by a murine myoblast cell line.

Authors:  M J Garlepp; W Chen; H Tabarias; M Baines; A Brooks; J McCluskey
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

6.  Identification of HIV protein-derived cytotoxic T lymphocyte (CTL) epitopes for their possible use as synthetic vaccine.

Authors:  C Brander; W J Pichler; G Corradin
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

Review 7.  Cancer immunotherapy and nanomedicine.

Authors:  Wei-Yun Sheng; Leaf Huang
Journal:  Pharm Res       Date:  2010-09-04       Impact factor: 4.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.